Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. Equipment
  3. cancer evaluation
Show results for
Products
Services
News
Articles
Downloads

Refine by

Cancer Evaluation Equipment & Supplies

8 equipment items found

UroGen - Model UGN-301 + UGN-201 (TLR 7 Agonist) - High-Grade Non-Muscle-Invasive Bladder Cancer (NMIBC)

UroGen - Model UGN-301 + UGN-201 (TLR 7 Agonist) - High-Grade Non-Muscle-Invasive Bladder Cancer (NMIBC)

Manufactured by:UroGen Pharma, Inc.   based inPrinceton, NEW YORK (USA)
UGN-301 is UroGen’s in-licensed anti-CTLA-4 antibody (zalifrelimab). UGN-201 is our proprietary formulation of imiquimod, a toll-like receptor 7 (TLR 7) agonist. When combined, these medicines stimulate both the innate (UGN-201) and adaptive (UGN-301) immune responses, both of which are important for fully harnessing the power of the immune system to fight ...
CONTACT SUPPLIER

Immunoscore - For Rectal Cancer

Immunoscore - For Rectal Cancer

Manufactured by:Veracyte   based inMarseille Cedex 9, FRANCE
Immunoscore® for Rectal Cancer can help identify patients with LARC who are at a low risk of relapse and may be good candidates for organ preservation. Immunoscore® is available through an Innovation Access Program while the company conducts clinical validation ...
CONTACT SUPPLIER

RNA  Therapeutics

RNA Therapeutics

Manufactured by:Auris Medical AG   based inBasel, SWITZERLAND
The OligoPhore™ / SemaPhore™ technology has been extensively and successfully tested with various siRNA and mRNA sequences in numerous disease models in mice. For the development of our first proprietary drug product, AM-401 (OligoPhore™ siRNA targeting KRAS), we have initiated a program of IND-enabling ...
CONTACT SUPPLIER

Starpharma - Prostate Cancer Drug Cabazitaxel

Starpharma - Prostate Cancer Drug Cabazitaxel

by:Starpharma Holdings Limited   based inMelbourne, AUSTRALIA
DEP® cabazitaxel is an enhanced version of leading prostate cancer drug cabazitaxel (Jevtana®). Cabazitaxel (Jevtana®) had global sales of €536M in 2020 despite having multiple US FDA “Black Box” warnings. ...
CONTACT SUPPLIER

SeraCare Seraseq - Whole Transcriptome RNA Seq Mix

SeraCare Seraseq - Whole Transcriptome RNA Seq Mix

Manufactured by:LGC SeraCare   based inMilford, MASSACHUSETTS (USA)
Whole transcriptome RNA sequencing allows for the analysis of fusion genes with potential clinical utility that currently cannot be detected using the limited genomic coverage of targeted NGS panels. Additionally, some clinical cancer testing labs are evaluating whole transcriptome panels for improved diagnostic yields and clinical utilization for NGS-based tumor profiling test reimbursements. ...
CONTACT SUPPLIER

MedChemExpress - Model Vociprotafib - 2172652-48-9

MedChemExpress - Model Vociprotafib - 2172652-48-9

Manufactured by:MedChemExpress LLC (MCE)   based inMonmouth Junction, NEW JERSEY (USA)
Vociprotafib (RMC-4630) is an orally active, selective and potent phosphatase SHP2 inhibitor, which blocks activation of the RAS-RAF-MEK-ERK signaling pathway with antitumor activity. Vociprotafib accelerates the time to, and increases the magnitude of, tumor regressions in Osimertinib (HY-15772)-sensitive EGFR-mutant tumors of ...
CONTACT SUPPLIER

Ecotest - Assure COVID-19 lgG/lgM Rapid Test

Ecotest - Assure COVID-19 lgG/lgM Rapid Test

Manufactured by:Able Diagnostics, Inc.   based inSan Diego, CALIFORNIA (USA)
The 1st Point-of-Care (POC) Antibody Test for COVID-19 with Fingerstick Whole Blood Authorized by FDA!. Click the link to review FDA NEWS RELEASE on Sept 23, 2020 in details: "FDA Authorizes First Point-of-Care Antibody Test for COVID-19" about Assure COVID-19 IgG/IgM Rapid Test Device. This authorization means that Fingerstick Blood Samples can now be tested in POC settings like Doctor's ...
CONTACT SUPPLIER

Percepta - Lung Cancer Diagnostics

Percepta - Lung Cancer Diagnostics

Manufactured by:Veracyte, Inc.   based inSouth San Francisco, CALIFORNIA (USA)
Avoiding unnecessary procedures, speeding time to diagnosis and appropriate treatment. Lung cancer is the leading cancer killer worldwide, causing approximately 1.8 million deaths each year. Veracyte’s comprehensive portfolio of lung cancer genomic tests is designed to improve outcomes for patients at each step of their journey, with an ultimate goal of saving more ...
CONTACT SUPPLIER
  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT